Search research articles
Contact Us
Filters
Showing results (661-670 of 875) with videos related to
Page
of 88
Sort By:
Ophthalmic Genetics
|
November 28, 2022
Effects of duration and number of symptoms on vision-related anxiety in patients with Inherited Retinal Diseases
Lilia T Popova, Rebhi O Abuzaitoun, Maria Fernanda Abalem, et al.
Cancer Research
|
November 1, 1991
Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin
S Isonishi, D K Hom, F B Thiebaut, et al.
Journal of Pediatric Surgery
|
October 5, 2001
Management of intestinal atresia in patients with gastroschisis
C L Snyder, K A Miller, R J Sharp, et al.
Arthritis and Rheumatism
|
May 30, 2006
AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases
Helen J Lachmann, Hugh J B Goodman, Peter A Andrews, et al.
Head & Neck
|
September 25, 2004
Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis
Genevieve A Andrews, Sichuan Xi, Rebecca G Pomerantz, et al.
Ophthalmic Genetics
|
May 4, 2023
Positive feedback loop between vision-related anxiety and self-reported visual difficulty
Lilia T Popova, Rebhi O Abuzaitoun, David M Fresco, et al.
Indian Journal of Orthopaedics
|
July 11, 2022
Patient and Surgical Factors Affecting Fusion Rates After Arthroscopic and Open Ankle Fusion: A Review of a High-Risk Cohort
Ashish B Shah, William Davis, Zachary L Littlefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer
T Nishimura, K Newkirk, R B Sessions, et al.
Head & Neck
|
July 15, 2010
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model
Daisuke Sano, David R Fooshee, Mei Zhao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 28, 2019
Sepiapterin Reductase Inhibition Leading to Selective Reduction of Inflammatory Joint Pain in Mice and Increased Urinary Sepiapterin Levels in Humans and Mice
Masahide Fujita, Débora da Luz Scheffer, Bruna Lenfers Turnes, et al.
Page
of 88
Search research articles
Search
Showing results (661-670 of 875) with videos related to
Sort By:
Page
of 88
Ophthalmic Genetics
|
November 28, 2022
Effects of duration and number of symptoms on vision-related anxiety in patients with Inherited Retinal Diseases
Lilia T Popova, Rebhi O Abuzaitoun, Maria Fernanda Abalem, et al.
Cancer Research
|
November 1, 1991
Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin
S Isonishi, D K Hom, F B Thiebaut, et al.
Journal of Pediatric Surgery
|
October 5, 2001
Management of intestinal atresia in patients with gastroschisis
C L Snyder, K A Miller, R J Sharp, et al.
Arthritis and Rheumatism
|
May 30, 2006
AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases
Helen J Lachmann, Hugh J B Goodman, Peter A Andrews, et al.
Head & Neck
|
September 25, 2004
Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis
Genevieve A Andrews, Sichuan Xi, Rebecca G Pomerantz, et al.
Ophthalmic Genetics
|
May 4, 2023
Positive feedback loop between vision-related anxiety and self-reported visual difficulty
Lilia T Popova, Rebhi O Abuzaitoun, David M Fresco, et al.
Indian Journal of Orthopaedics
|
July 11, 2022
Patient and Surgical Factors Affecting Fusion Rates After Arthroscopic and Open Ankle Fusion: A Review of a High-Risk Cohort
Ashish B Shah, William Davis, Zachary L Littlefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer
T Nishimura, K Newkirk, R B Sessions, et al.
Head & Neck
|
July 15, 2010
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse model
Daisuke Sano, David R Fooshee, Mei Zhao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 28, 2019
Sepiapterin Reductase Inhibition Leading to Selective Reduction of Inflammatory Joint Pain in Mice and Increased Urinary Sepiapterin Levels in Humans and Mice
Masahide Fujita, Débora da Luz Scheffer, Bruna Lenfers Turnes, et al.
Page
of 88